Healthcare is a top agenda item for the 115th Congress. Komen sent a letter to Congressional Leadership, urging them to ensure access to timely, affordable, high-quality health insurance and perseveration of key patient protections during this ongoing debate. Komen’s 2017-2018 Advocacy Priorities are:
- Support for expanded federal funding for biomedical research, especially breast cancer research at the National Institutes of Health (NIH) and the Department of Defense (DOD);
- Support state and federal funding for the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and support policies to modernize NBCCEDP state programs to expand eligibility and provide breast cancer screening and diagnostic services for additional populations;
- Advocate for policies that improve insurance coverage for breast cancer treatments and screening, specifically pertaining to increased access to drug therapies and limiting out-of-pocket costs for diagnostic mammography.
- Evaluate state and federal policies to increase awareness, education and access to clinical trials for all patient populations.
If you’re interested in sharing a letter with your congressional contacts, please e-mail us to be updated on all legislative calls to action for advocacy, make sure you are part of our advocacy alliance.